Disseminated strongyloidiasis complicating glioblastoma therapy: A case report

Journal of Neuro-Oncology

Volumn 94, Issue 3, 2009, Pages 439-443

  Aregawi, Dawit ^a   Lopez, David ^b   Wick, Mark ^b   Scheld, W Michael ^b   Schiff, David ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Corticosteroid; Glioblastoma; Strongyloidiasis; Syndrome of inappropriate antidiuretic hormone secretion; Temozolomide

Indexed keywords

ALBENDAZOLE; ANTIBIOTIC AGENT; DEMECLOCYCLINE; DESMOPRESSIN; DEXAMETHASONE; IMMUNOGLOBULIN G; IVERMECTIN; METFORMIN; NORADRENALIN; PHENYTOIN; PIPERACILLIN PLUS TAZOBACTAM; TEMOZOLOMIDE; VANCOMYCIN;

ABDOMINAL DISTENSION; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING DISORDER; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; DECREASED APPETITE; DIABETES INSIPIDUS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENTEROCOCCUS; ESCHERICHIA COLI; FATIGUE; FEMALE; FLUID RESUSCITATION; GLIOBLASTOMA; HEADACHE; HERPES SIMPLEX VIRUS; HUMAN; HYPONATREMIA; HYPOTENSION; IMMUNOCOMPROMISED PATIENT; IMMUNOGLOBULIN BLOOD LEVEL; KLEBSIELLA PNEUMONIAE; LUNG LAVAGE; MENTAL DISEASE; PROPHYLAXIS; PUNCH BIOPSY; RESPIRATORY FAILURE; SMALL INTESTINE OBSTRUCTION; STRONGYLE INFECTION; STRONGYLOIDES STERCORALIS; TACHYCARDIA; URINE CULTURE; VASOPRESSIN RELEASE; VOMITING; WEIGHT REDUCTION;

ALBENDAZOLE; ANTIPROTOZOAL AGENTS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; IVERMECTIN; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; STRONGYLOIDIASIS;

EID: 69249239136     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9878-4     Document Type: Article

References (37)

1. Su YB, Sohn S, Krown SE, Livingston PO, Wolchok JD, Quinn C et al (2004) Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: A toxicity with therapeutic implications. J Clin Oncol 22(4):610-616. doi: 10.1200/JCO.2004.07.060
2. Tosoni A, Cavallo G, Ermani M, Scopece L, Franceschi E, Ghimenton C et al (2006) Is protracted low-dose temozolomide feasible in glioma patients? Neurology 66(3):427-429. doi: 10.1212/ 01.wnl.0000196465.83423.ec
3. Hahn BH, MacDermott RP, Jacobs SB, Pletscher LS, Beale MG (1980) Immunosuppressive effects of low doses of glucocorticoids: Effects on autologous and allogeneic mixed leukocyte reactions. J Immunol 124(6):2812-2817
4. Ganiere V, Christen G, Bally F, Guillou L, Pica A, de Ribaupierre S et al. (2006) Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide. Nat Clin Pract Oncol 3(6):339-343; quiz following 343
5. Chheda MG, Drappatz J, Greenberger NJ, Kesari S, Weiss SE, Gigas DC et al (2007) Hepatitis B reactivation during glioblastoma treatment with temozolomide: A cautionary note. Neurology 68(12):955-956. doi: 10.1212/ 01.wnl.0000259430.48835.b5
6. Choi JD, Powers CJ, Vredenburgh JJ, Friedman AH, Sampson JH (2008) Cryptococcal meningitis in patients with glioma: A report of two cases. J Neurooncol 89(1):51-53. doi: 10.1007/s11060-008-9581-x
7. Berk SL, Verghese A, Alvarez S, Hall K, Smith B (1987) Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med 147(7):1257-1261. doi: 10.1001/ archinte.147.7.1257
8. Zygmunt DJ (1990) Strongyloides stercoralis. Infect Control Hosp Epidemiol 11(9):495-497
9. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987-996. doi: 10.1056/NEJMoa043330
10. Caldenhoven E, Liden J, Wissink S, van de Stolpe A, Raaijmakers J, Koenderman L et al (1995) Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9(4):401-412. doi: 10.1210/ me.9.4.401
11. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G (1992) A mechanism for the antiinflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 89(21):9991-9995. doi: 10.1073/pnas.89.21.9991
12. Baus E, Andris F, Dubois PM, Urbain J, Leo O (1996) Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes. J Immunol 156(12):4555-4561
13. Bischof F, Melms A (1998) Glucocorticoids inhibit CD40 ligand expression of peripheral CD4+ lymphocytes. Cell Immunol 187(1):38-44. doi: 10.1006/ cimm.1998.1308
14. Barnes PJ, Adcock I (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14(12):436-441. doi: 10.1016/ 0165-6147(93)90184-L
15. Wilckens T, De Rijk R (1997) Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 18(9):418-424. doi: 10.1016/S0167-5699(97)01111-0
16. Fardet L, Genereau T, Cabane J, Kettaneh A (2006) Severe strongyloidiasis in corticosteroid-treated patients. Clin Microbiol Infect 12(10):945-947. doi: 10.1111/j.1469-0691.2006.01443.x
17. Simpson WG, Gerhardstein DC, Thompson JR (1993) Disseminated Strongyloides stercoralis infection. South Med J 86(7):821-825. doi: 10.1097/00007611-199307000-00022
18. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB (1981) Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 3(3):397-407
19. Genta RM (1992) Dysregulation of strongyloidiasis: A new hypothesis. Clin Microbiol Rev 5(4):345-355
20. Thomas MC, Costello SA (1998) Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgery. Int J Clin Pract 52(7):520-521
21. Link K, Orenstein R (1999) Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis. South Med J 92(7):728-731. doi: 10.1097/ 00007611-199907000-00016
22. Newberry AM, Williams DN, Stauffer WM, Boulware DR, Hendel-Paterson BR, Walker PF (2005) Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest 128(5):3681-3684. doi: 10.1378/chest.128.5.3681
23. Siddiqui AA, Berk SL (2001) Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33(7):1040-1047. doi: 10.1086/322707
24. Satoh M, Kokaze A (2004) Treatment strategies in controlling strongyloidiasis. Expert Opin Pharmacother 5(11):2293-2301. doi: 10.1517/ 14656566.5.11.2293
25. Concha R, Harrington W Jr, Rogers AI (2005) Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol 39(3):203-211. doi: 10.1097/01.mcg.0000152779.68900.33
26. Sato Y, Kobayashi J, Toma H, Shiroma Y (1995) Efficacy of stool examination for detection of strongyloides infection. Am J Trop Med Hyg 53(3):248-250
27. Genta RM (1988) Predictive value of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis. Am J Clin Pathol 89(3):391-394
28. Sato Y, Takara M, Otsuru M (1985) Detection of antibodies in strongyloidiasis by enzyme-linked immunosorbent assay (ELISA). Trans R Soc Trop Med Hyg 79(1):51-55. doi: 10.1016/0035-9203(85)90233-0
29. Hallsworth MP, Litchfield TM, Lee TH (1992) Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils. Immunology 75(2):382-385
30. Wallen N, Kita H, Weiler D, Gleich GJ (1991) Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 147(10):3490-3495
31. Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC (2004) Complicated and fatal strongyloides infection in Canadians: Risk factors, diagnosis and management. CMAJ 171(5):479-484. doi: 10.1503/ cmaj.1031698
32. Hughes R, McGuire G (2001) Delayed diagnosis of disseminated strongyloidiasis. Intensive Care Med 27(1):310-312. doi: 10.1007/ s001340000798
33. Pornsuriyasak P, Niticharoenpong K, Sakapibunnan A (2004) Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: A case report of intractable strongyloidiasis. Southeast Asian J Trop Med Public Health 35(3):531-534
34. Reddy TS, Myers JW (2003) Syndrome of inappropriate secretion of antidiuretic hormone and nonpalpable purpura in a woman with Strongyloides stercoralis hyperinfection. Am J Med Sci 325(5):288-291. doi: 10.1097/00000441-200305000-00007
35. Seet RC, Gong LL, Tambyath PA (2005) Image of the month. Strongyloides stercoralis hyperinfection and syndrome of inappropriate secretion of antidiuretic hormone. Gastroenterology. 128(1):8, 252
36. Hayashi E, Ohta N, Yamamoto H (2007) Syndrome of inappropriate secretion of antidiuretic hormone associated with strongyloidiasis. Southeast Asian J Trop Med Public Health 38(2):239-246
37. Wachter RM, Burke AM, MacGregor RR (1984) Strongyloides stercoralis hyperinfection masquerading as cerebral vasculitis. Arch Neurol 41(11):1213-1216